A Review of Advances in Molecular Imaging of Rheumatoid Arthritis: From In Vitro to Clinic Applications Using Radiolabeled Targeting Vectors with Technetium-99m.
99mTc
RA
SPECT/CT
autoimmune disorder
computed tomography
nuclear medicine
radiopharmaceuticals
scintigraphy
single-photon emission computed tomography
synovitis
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
12 Jun 2024
12 Jun 2024
Historique:
received:
22
04
2024
revised:
24
05
2024
accepted:
07
06
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
Rheumatoid arthritis (RA) is a systemic autoimmune disorder caused by inflammation of cartilaginous diarthrodial joints that destroys joints and cartilage, resulting in synovitis and pannus formation. Timely detection and effective management of RA are pivotal for mitigating inflammatory arthritis consequences, potentially influencing disease progression. Nuclear medicine using radiolabeled targeted vectors presents a promising avenue for RA diagnosis and response to treatment assessment. Radiopharmaceutical such as technetium-99m (
Identifiants
pubmed: 38929734
pii: life14060751
doi: 10.3390/life14060751
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : National Center 5 "National Biodiversity Future Center", theme "Bio-diversità", in the frame-work of the Piano Nazionale di Ripresa e resilienza, Mission 4 Component 2 Investment 1.4, funded by the European Union-NextGenerationEU, identification code CN00
ID : CN00000033, CUP B73C21001300006